The mechanisms involved in the apoptotic effect of
LCY-2-CHO [9-(2-chlorobenzyl)-9H-
carbazole-3-carbaldehyde], a synthetic
carbazole derivative identified as an anti-inflammatory compound, were studied. Cell cycle analysis by
propidium iodide staining in human THP-1 monocytic
leukemia cells showed the ability of
LCY-2-CHO to increase cell population in sub-G1 stage with time- and concentration-dependent manners. LCY-2-CHO-mediated cell death was also demonstrated by
DNA laddering and was not related to the release of
lactate dehydrogenase. Apoptosis in THP-1 cells induced by
LCY-2-CHO was accompanied by the Bid cleavage, collapse of mitochondrial transmembrane potential, the release of
cytochrome c and the activation of
caspase-3. The apoptotic effect of
LCY-2-CHO was diminished by the presence of zVEID-fmk (caspase-6 inhibitor), zIETD-fmk (caspase-8 inhibitor), and
zVAD-fmk (non-selective
caspase inhibitor), but was not altered by several
antioxidants, and
cathepsin inhibitor. The Bid cleavage and loss of mitochondrial transmembrane potential, but not the
cytochrome c release, were reversed by zIETD-fmk. Comparing the cell selectivity of
LCY-2-CHO, we found T-cell acute lymphoblastic CEM
leukemia cells were sensitive to 1 microM
LCY-2-CHO,
acute myeloid leukemia HL-60 cells underwent apoptosis
at 10 microM, while adherent
cancer cells, such as PC3, HT29 and MCF-7, were resistant to 30 microM
LCY-2-CHO within 24-h incubation. Taken together in the present study, we demonstrated
LCY-2-CHO might be apoptotic for malignant hematopoietic cells but not anchorage-dependent cells. This action is mediated by an intrinsic
caspase-dependent apoptotic event involving mitochondria.